Infusion Therapy Center

Reliable treatments for better wellness.

Medical drip in front of monitor

REGEN-COV Infusion for Treatment

Regeneron EUA Information for Patients

The Emergency Use Authorization (EUA) allows REGEN-COV infusion for the treatment of mild to moderate COVID-19 in adult and pediatric patients (12 years and older, weighing at least 40 kg) who:

  • Have a positive SARS-CoV-2 viral test

  • Are at high risk for progression to severe COVID-19, including hospitalization or death

Eligibility Requirements

You Must Meet All of the Following Criteria:

  • Positive SARS-CoV-2 test

  • Within 10 days of initial symptom onset

  • Age 12 years or older

  • Weight at least 88 lbs (40 kg)

  • Oxygen saturation (SpO2) ≥94%

Gloved hand holding IV drip tube

And at Least One of the Following Risk Factors:

  • Age 65 years or older

  • BMI >25 kg/m² (or age 12–17 with BMI ≥85th percentile)

  • Chronic kidney disease

  • Diabetes

  • Immunosuppressive disease or immunosuppressive treatment

  • Cardiovascular disease (including congenital heart disease) or hypertension

  • Chronic lung disease (COPD, moderate to severe asthma, interstitial lung disease, cystic fibrosis, pulmonary hypertension)

  • Sickle cell disease

  • Neurodevelopmental disorders (e.g., cerebral palsy), genetic or metabolic syndromes, or severe congenital anomalies

  • Medical-related technological dependence (e.g., tracheostomy or gastrostomy)

Important Notice

OB approval is required if the patient is pregnant.